News from issuers of financial instruments admitted to trading on BSE-Sofia

News

By date From date: Search in news
By period From date: To date:
By title
By code

07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Elpharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Sopharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Sopharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Rositsa Doneva under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Ognyan Donev under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
07-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Sopharma AD hereby informs that on 06 December 2017 the company bought back on BSE-Sofia 3,061,292 own shares at the total value of BGN 13,071,716.84 respectively at BGN 4.27 average price per share, representing 2.271% of the share capital of the company.
The total number of treasury shares held after this transaction is 9,146,785 representing 6.786% of the share capital of the company, thus Sopharma AD passed the threshold of 5% for treasury shares.
The entire piece of news is posted in English on the financial website X3News.